Company: KNRX
Filing Date: 2025-09-22
Form Type: F-1/A
Source: 0001493152-25-014499
Chunk: 236

Company: KNOREX LTD.
Filing Date: 2025-09-22
Form: F-1/A
Chunk 236
---
 | ) |     |     |          (576,152 | ) |
| Other technology and development expenses              |     |                    |          (401,746 | ) |     |     |          (356,180 | ) |
| Other general and administrative expenses              |     |                    |          (956,064 | ) |     |     |        (1,452,780 | ) |
| Other segment expenses (income)                        |     |                    |          (317,220 | ) |     |     |            26,762 |   |
| Provision for income taxes                             |     |                    |           (58,223 | ) |     |     |           (33,239 | ) |
| Net loss                                               |     | $                  |        (5,883,611 | ) |     | $   |        (7,964,772 | ) |

Note 17 – Subsequent events

The Company evaluated subsequent events and transactions that occurred after the date of these consolidated financial statements were issued. Based on this review, except as disclosed below, the Company did not identify any other subsequent events that would require adjustment or disclosure in the consolidated financial statements.

Cancellation of warrants

In January 2025, a batch of 4,527,387 warrants was canceled and reissued with expiry dates of between March 4, 2026 and March 19, 2028, and exercise price of between US$1.497 and US$2.074. A second batch of 251,608 warrants was canceled and reissued with exercise price of US$2.60 and expiry date of June 30, 2027.

Exercise of warrants

In January 2025, a total of 164,713 warrants were exercised to subscribe for 164,713 Class A Ordinary Shares for a total consideration of approximately US$0.2 million.

Amendment to the convertible note agreements

In February 2025, the Company signed the Amendment to the convertible note agreements for the aforementioned nine convertible notes (Note 7) to extend the maturity date to be due in June 2026. The interest rate increased from 8% per annum to 12% per annum beginning in February 2025. The conversion price of the D-2 Nots also amended to be 50% (amended from 70%) of the IPO price or next round of financing.

Between January and June 2025, the Company
secured approximately US$1.9 million in short-term debt financing from